ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 137 filers reported holding ARGENX SE in Q2 2019. The put-call ratio across all filers is 2.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787 | -15.3% | 1,602 | -35.8% | 0.08% | -21.2% |
| Q1 2023 | $929 | -99.9% | 2,494 | -18.9% | 0.10% | 0.0% |
| Q3 2022 | $1,086,000 | +391.4% | 3,076 | +339.4% | 0.10% | +518.8% |
| Q1 2022 | $221,000 | -57.5% | 700 | -62.9% | 0.02% | -56.8% |
| Q1 2021 | $520,000 | +75.1% | 1,888 | +43.1% | 0.04% | +8.8% |
| Q2 2020 | $297,000 | +36.9% | 1,319 | -24.1% | 0.03% | +183.3% |
| Q1 2019 | $217,000 | -49.7% | 1,738 | -67.6% | 0.01% | -47.8% |
| Q1 2018 | $431,000 | – | 5,357 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |